Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis.

Devogelaer JP, Adler RA, Recknor C, See K, Warner MR, Wong M, Krohn K.

J Rheumatol. 2010 Jan;37(1):141-8. doi: 10.3899/jrheum.090411. Epub 2009 Nov 16.

PMID:
19918047
2.

Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.

Brixen KT, Christensen PM, Ejersted C, Langdahl BL.

Basic Clin Pharmacol Toxicol. 2004 Jun;94(6):260-70. Review.

3.

[Efficacy of teriparatide in treatment of glucocorticoid-induced osteoporosis].

Soen S.

Clin Calcium. 2012 Mar;22(3):315-20. doi: CliCa1203315320. Review. Japanese.

PMID:
22370297
4.

[Glucocorticoid and bone].

Soen S.

Clin Calcium. 2014 Jun;24(6):829-36. doi: CliCa1406829836. Review. Japanese.

PMID:
24870833
5.

[Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios].

Di Munno O, Delle Sedie A.

Reumatismo. 2011;63(2):67-79. Review. Italian.

6.

Anabolic therapies for osteoporosis.

Uihlein AV, Leder BZ.

Endocrinol Metab Clin North Am. 2012 Sep;41(3):507-25. doi: 10.1016/j.ecl.2012.05.002. Epub 2012 Jun 20. Review.

PMID:
22877427
7.

Effects of different impact exercise modalities on bone mineral density in premenopausal women: a meta-analysis.

Martyn-St James M, Carroll S.

J Bone Miner Metab. 2010 May;28(3):251-67. doi: 10.1007/s00774-009-0139-6. Epub 2009 Dec 15. Review.

PMID:
20013013
8.

The use of PTH in the treatment of osteoporosis.

Borba VZ, MaƱas NC.

Arq Bras Endocrinol Metabol. 2010 Mar;54(2):213-9. Review.

9.

[Glucocorticoid and Bone. Updated Japanese guidelines for the management of glucocorticoid-induced osteoporosis].

Suzuki Y.

Clin Calcium. 2014 Sep;24(9):1309-18. doi: CliCa140913091318. Review. Japanese.

PMID:
25177003
10.

Glucocorticoid-induced osteoporosis and parathyroid hormone.

Carpinteri R, Porcelli T, Mejia C, Patelli I, Bilezikian JP, Canalis E, Angeli A, Giustina A, Mazziotti G.

J Endocrinol Invest. 2010;33(7 Suppl):16-21. Review.

PMID:
20938221
11.

Management of osteoporosis in a pre-menopausal woman.

Bhalla AK.

Best Pract Res Clin Rheumatol. 2010 Jun;24(3):313-27. doi: 10.1016/j.berh.2010.01.006. Review.

PMID:
20534366
12.

Management of glucocorticoid-induced osteoporosis.

Compston J.

Nat Rev Rheumatol. 2010 Feb;6(2):82-8. doi: 10.1038/nrrheum.2009.259. Review.

PMID:
20125175
13.

[Glucocorticoid-induced osteoporosis : treatment update].

Soen S.

Clin Calcium. 2012 Feb;22(2):229-35. doi: CliCa1202229235. Review. Japanese.

PMID:
22298077
14.

[Secondary osteoporosis UPDATE. Clinical significance of glucocorticoid-induced osteoporosis].

Suzuki Y, Sato S.

Clin Calcium. 2010 May;20(5):645-53. doi: CliCa1005645653. Review. Japanese.

PMID:
20445275
15.
16.

Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.

Bultink IE, Baden M, Lems WF.

Expert Opin Pharmacother. 2013 Feb;14(2):185-97. doi: 10.1517/14656566.2013.761975. Epub 2013 Jan 14. Review.

PMID:
23317448
17.

Glucocorticoid-induced osteoporosis.

Silverman SL, Lane NE.

Curr Osteoporos Rep. 2009 Mar;7(1):23-6. Review.

PMID:
19239826
18.

[Combination or sequential treatment using PTH and anti-resorption therapies].

Suzuki H, Takeuchi Y.

Clin Calcium. 2012 Mar;22(3):415-20. doi: CliCa1203415420. Review. Japanese.

PMID:
22370309
19.

[Diagnosis, clinical feature and treatment of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis].

Nakayama H.

Nihon Rinsho. 2007 Nov 28;65 Suppl 9:499-503. Review. Japanese. No abstract available.

PMID:
18161156
20.

[Osteoanabolics and the forthcoming drugs for the treatment of osteoporosis].

Grazio S.

Reumatizam. 2014;61(2):95-9. Review. Croatian.

PMID:
25427402
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk